Azathioprine

Revision as of 02:52, 9 February 2016 by Janelim (talk | contribs) (pharmacology)

Administration

  • Type: immunosuppressant
  • Dosage Forms: 50
  • Routes of Administration: PO (IV form unavailable in US)
  • Common Trade Names: Azasan, Imuran

Adult Dosing

Kidney transplant rejection prophylaxis

  • 1-3 mg/kg PO qd
  • Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary

Rheumatoid arthritis, severe

  • 1-2.5 mg/kg/day PO divided qd-bid
  • Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk

Crohns Disease

  • 100-250 mg PO qd
  • Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance and fistulizing disease, steroid-sparing effects

Ulcerative colitis

  • 100-250 mg PO qd
  • Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance, steroid-sparing effects

Pediatric Dosing

Kidney transplant rejection prophylaxis

  • 1-3 mg/kg PO qd
  • Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary

Juvenile idiopathic arthritis, severe

  • 1-2.5 mg/kg/day PO divided qd-bid
  • Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk

Special Populations

Renal Dosing

  • Adult: CrCl 10-50: decr. dose 25%; CrCl <10: decr. dose 50%; HD: give 0.25 mg/kg supplement; PD: not defined
  • Pediatric: CrCl 10-50: decr. dose 25% or give q36h; CrCl <10: decr. dose 50% or give q48h; HD: give supplement; PD: not defined

Hepatic Dosing

  • Adult: not defined; caution advised
  • Pediatric: not defined; caution advised

Contraindications

  • Allergy to class/drug
  • pregnancy (RA use)
  • caution if renal impairment
  • caution if prior alkylating agents

Adverse Reactions

Serious

  • leukopenia
  • thrombocytopenia
  • anemia
  • myelosuppression
  • immunosuppression
  • infection
  • PML
  • GI hypersensitivity rxn
  • pancreatitis
  • hepatotoxicity
  • hepatic veno-occlusive dz
  • lymphoma
  • malignancy
  • acute febrile neutrophilic dermatosis

Common

  • leukopenia
  • thrombocytopenia
  • anemia
  • infection
  • nausea
  • vomiting
  • anorexia
  • diarrhea
  • ALT, AST elevated
  • malaise
  • myalgia
  • fever
  • rash
  • malignancy

Pharmacology

  • Half-life: 5 hours
  • Metabolism: liver extensively, erythrocytes; CYP450
  • Excretion: bile, urine (1-2% unchanged)

Mechanism of Action

Comments

See Also

References